Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...

The origin of life on Earth becomes even more fascinating and complex as we peer into the mysterious world of viruses. Said to have existed since living cells first appeared, these microscopic ...

Amgen Inc. raises 2025 revenue guidance on strong Repatha and Imdelltra sales and dividend hike. Click for this AMGN update.

Agreement grants Lilly rights to employ Sangamo’s novel proprietary capsid, STAC-BBB, for up to five potential disease targets Sangamo to receive an $18 million upfront license fee and is eligible to ...

Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits their availability for those who need them. Part of the reason for the cost ...

Inside a cell, a single protein emerges from from the cell’s protein-making machinery, then another, and another. They move about—bouncing into one another, wriggling around, and drifting away again.

Once perceived as mere pathogens, adenoviruses have transformed remarkably, becoming indispensable allies in the fight against genetic disorders. In an era where medical innovation is paramount, ...

University of Chicago researchers have discovered how HIV’s capsid structure enables the virus to enter a cell’s nucleus, providing new insights into the virus’s replication mechanism and potential ...

A new study has revealed how HIV squirms its way into the nucleus as it invades a cell. Because viruses have to hijack someone else's cell to replicate, they've gotten very good at it -- inventing all ...

Because viruses have to hijack someone else’s cell to replicate, they’ve gotten very good at it—inventing all sorts of tricks. A new study from two University of Chicago scientists has revealed how ...

You are free to share (copy and redistribute) this article in any medium or format and to adapt (remix, transform, and build upon) the material for any purpose, even commercially within the parameters ...